TD Cowen Lowers Axon Enterprise (NASDAQ:AXON) Price Target to $825.00

Axon Enterprise (NASDAQ:AXON) had its price target reduced by TD Cowen from $950.00 to $825.00 in a note issued to investors on Wednesday,Benzinga reports. The brokerage presently has a “buy” rating on the biotechnology company’s stock. TD Cowen’s price objective would indicate a potential upside of 110.74% from the stock’s previous close.

Other equities research analysts also recently issued research reports about the stock. Piper Sandler decreased their target price on shares of Axon Enterprise from $753.00 to $690.00 and set an “overweight” rating for the company in a research note on Wednesday, February 25th. Wall Street Zen upgraded shares of Axon Enterprise from a “sell” rating to a “hold” rating in a research note on Saturday, February 28th. Robert W. Baird set a $800.00 target price on shares of Axon Enterprise in a research note on Wednesday, February 25th. UBS Group decreased their target price on shares of Axon Enterprise from $610.00 to $570.00 and set a “neutral” rating for the company in a research note on Wednesday, February 25th. Finally, William Blair restated an “outperform” rating on shares of Axon Enterprise in a research report on Tuesday, February 3rd. Sixteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $755.88.

Axon Enterprise Stock Performance

Shares of AXON traded up $18.61 during mid-day trading on Wednesday, hitting $391.48. 932,025 shares of the company’s stock were exchanged, compared to its average volume of 997,668. Axon Enterprise has a fifty-two week low of $362.73 and a fifty-two week high of $885.91. The firm has a market capitalization of $31.47 billion, a P/E ratio of 257.40, a P/E/G ratio of 8.81 and a beta of 1.61. The business’s 50 day moving average is $473.50 and its two-hundred day moving average is $572.61. The company has a current ratio of 2.53, a quick ratio of 2.29 and a debt-to-equity ratio of 0.53.

Axon Enterprise (NASDAQ:AXON) last announced its earnings results on Tuesday, February 24th. The biotechnology company reported $2.15 earnings per share for the quarter, topping the consensus estimate of $1.60 by $0.55. Axon Enterprise had a net margin of 4.48% and a return on equity of 2.82%. The business had revenue of $796.72 million during the quarter, compared to the consensus estimate of $755.29 million. During the same quarter in the prior year, the firm earned $2.08 earnings per share. The business’s quarterly revenue was up 38.5% compared to the same quarter last year. On average, equities analysts expect that Axon Enterprise will post 5.8 earnings per share for the current year.

Insider Buying and Selling

In other Axon Enterprise news, CEO Patrick W. Smith sold 10,000 shares of the stock in a transaction dated Wednesday, February 25th. The shares were sold at an average price of $500.24, for a total value of $5,002,400.00. Following the completion of the transaction, the chief executive officer directly owned 3,090,997 shares of the company’s stock, valued at approximately $1,546,240,339.28. This trade represents a 0.32% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Isaiah Fields sold 2,000 shares of the stock in a transaction dated Friday, February 27th. The shares were sold at an average price of $535.01, for a total transaction of $1,070,020.00. Following the completion of the transaction, the insider directly owned 55,588 shares of the company’s stock, valued at approximately $29,740,135.88. This trade represents a 3.47% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 13,855 shares of company stock valued at $7,109,828 in the last 90 days. 5.70% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the stock. Stone House Investment Management LLC purchased a new position in Axon Enterprise in the third quarter valued at about $29,000. New Millennium Group LLC purchased a new position in shares of Axon Enterprise during the 3rd quarter worth approximately $29,000. Darwin Wealth Management LLC purchased a new position in shares of Axon Enterprise during the 2nd quarter worth approximately $37,000. Root Financial Partners LLC purchased a new position in shares of Axon Enterprise during the 3rd quarter worth approximately $34,000. Finally, Creative Financial Designs Inc. ADV purchased a new position in shares of Axon Enterprise during the 4th quarter worth approximately $28,000. 79.08% of the stock is owned by hedge funds and other institutional investors.

Key Stories Impacting Axon Enterprise

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Morgan Stanley reiterated a constructive view highlighting AI-driven growth as a compelling entry after the pullback; analyst note frames recent weakness as a buying opportunity tied to Axon’s software/AI expansion. Axon: AI-Driven Growth Outlook Creates Compelling Entry Point After Share Pullback
• Positive Sentiment: Axon announced three new AI tools at Axon Week (Axon Vision, Axon Assistant and expanded real‑time intelligence) that could accelerate recurring software revenue and deepen product stickiness with public‑safety customers. This is the primary operational catalyst supporting upside sentiment. Axon Tackles Public Safety’s Data Overload With Three New AI Tools
• Neutral Sentiment: Coverage pieces are flagging AXON as an oversold/turnaround candidate and as a play on unmanned aerial vehicle (UAV) exposure — useful framing for long‑term investors but not immediate price drivers. 2 Oversold Stocks Set for a Comeback and 1 We Brush Off
• Neutral Sentiment: AXON hit a 52‑week low, drawing attention from value/contrarian analysts — a data point that often attracts both bargain hunters and short‑term sellers. Axon stock hits 52-week low at 396.41 USD
• Negative Sentiment: Share weakness this week was driven by headlines about new legal risks tied to Axon’s HQ and related litigation, which prompted analyst price‑target cuts and increased uncertainty around expenses/legal liabilities. Axon Stock Plunged on Tuesday. Is This a Buying Opportunity?
• Negative Sentiment: Multiple outlets reported a >10% intraday decline amid analyst downgrades/price‑target trims and commentary that the stock lagged peers, which fed momentum selling. Why Axon (AXON) Shares Are Trading Lower Today
• Negative Sentiment: Broader market pressure — including rising U.S.‑Iran tensions and weaker macro data — weighed on tech and growth names, exacerbating AXON’s decline as investors fled higher‑multiple stocks. Why Axon Shares Are Sliding Tuesday?

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.